Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Frontera London

- PMLiVE

Building Europe’s next breakthrough biotechs

Start Codon's Daniel Rooke on fostering biotech success in Cambridge, UK

- PMLiVE

NICE unveils long-awaited review of methodologies

Use of quality of life measures to be reviewed

- PMLiVE

Boris Johnson is new PM – but opposition to his Brexit plans mount

Brexit rhetoric unrealistic, suggests biotech leader

- PMLiVE

Vertex files cystic fibrosis triple therapy with FDA

A landmark for company - but pricing controversy awaits

- PMLiVE

Acadia’s drive to extend use of Nuplazid hits a wall

Shares in company down

- PMLiVE

Intec sounds a sad note as Accordion Parkinson’s trial fails

Intec’s lifeline now is Novartis partnership

- PMLiVE

Re-imagining content supply chains for a next-gen customer experience in pharma

by Marc Valdiviezo

- PMLiVE

Takeda makes Crohn’s disease case for subcutaneous Entyvio

Hopes to aid growth

- PMLiVE

Gilead continues its exec clear-out, licenses antivirals from Novartis

Long-standing R&D chief to depart

- PMLiVE

J&J files new Darzalex formulation in US and Europe

Subcutaneous version could help fend of Sanofi rival

- PMLiVE

Boehringer taps Korea’s Bridge for Ofev follow-up

Latest in a string of in-licensing deals

- PMLiVE

Pear Therapeutics submits latest digital therapeutic, insomnia and depression treatment

CBT-based treatment targets insomnia and depression

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links